(19)
(11) EP 1 107 738 A1

(12)

(43) Date of publication:
20.06.2001 Bulletin 2001/25

(21) Application number: 99968215.6

(22) Date of filing: 26.08.1999
(51) International Patent Classification (IPC)7A61K 9/16, A61K 9/22, A61K 9/58
(86) International application number:
PCT/US9919/575
(87) International publication number:
WO 0012/067 (09.03.2000 Gazette 2000/10)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 27.08.1998 US 98154 P

(71) Applicant: Bristol-Myers Squibb Company
Princeton, NJ 08543-4000 (US)

(72) Inventor:
  • RAYBURN, James, W.
    Evansville, IN 47720 (US)

(74) Representative: Bentz, Jean-Paul et al
Cabinet Weinstein,56 A, rue du Faubourg Saint-Honoré
75008 Paris
75008 Paris (FR)

   


(54) NOVEL PHARMACEUTICAL SALT FORM